BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 16964380)

  • 1. KIT/stem cell factor expression in premalignant and malignant lesions of the colon mucosa in relationship to disease progression and outcomes.
    Bellone G; Smirne C; Carbone A; Buffolino A; Scirelli T; Prati A; Solerio D; Pirisi M; Valente G; Nano M; Emanuelli G
    Int J Oncol; 2006 Oct; 29(4):851-9. PubMed ID: 16964380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth stimulation of colorectal carcinoma cells via the c-kit receptor is inhibited by TGF-beta 1.
    Bellone G; Silvestri S; Artusio E; Tibaudi D; Turletti A; Geuna M; Giachino C; Valente G; Emanuelli G; Rodeck U
    J Cell Physiol; 1997 Jul; 172(1):1-11. PubMed ID: 9207920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and molecular evidence for c-kit receptor as a therapeutic target in neuroblastic tumors.
    Uccini S; Mannarino O; McDowell HP; Pauser U; Vitali R; Natali PG; Altavista P; Andreano T; Coco S; Boldrini R; Bosco S; Clerico A; Cozzi D; Donfrancesco A; Inserra A; Kokai G; Losty PD; Nicotra MR; RaschellĂ  G; Tonini GP; Dominici C
    Clin Cancer Res; 2005 Jan; 11(1):380-9. PubMed ID: 15671569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of SCF splice variants in human melanocytes and melanoma cell lines: potential prognostic implications.
    Welker P; Schadendorf D; Artuc M; Grabbe J; Henz BM
    Br J Cancer; 2000 Apr; 82(8):1453-8. PubMed ID: 10780526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-expression of KIT receptor and its ligand stem cell factor in Merkel cell carcinoma.
    Krasagakis K; Kruger-Krasagakis S; Eberle J; Tsatsakis A; Tosca AD; Stathopoulos EN
    Dermatology; 2009; 218(1):37-43. PubMed ID: 19001805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression of stem cell factor and c-kit receptor in human asthmatic airways.
    Al-Muhsen SZ; Shablovsky G; Olivenstein R; Mazer B; Hamid Q
    Clin Exp Allergy; 2004 Jun; 34(6):911-6. PubMed ID: 15196279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant activation of c-kit protects colon carcinoma cells against apoptosis and enhances their invasive potential.
    Bellone G; Carbone A; Sibona N; Bosco O; Tibaudi D; Smirne C; Martone T; Gramigni C; Camandona M; Emanuelli G; Rodeck U
    Cancer Res; 2001 Mar; 61(5):2200-6. PubMed ID: 11280787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dermal stem cell factor and c-kit are overexpressed in melasma.
    Kang HY; Hwang JS; Lee JY; Ahn JH; Kim JY; Lee ES; Kang WH
    Br J Dermatol; 2006 Jun; 154(6):1094-9. PubMed ID: 16704639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of stem cell factor and c-kit in human malignant fibrous histiocytoma cell line (TNMY1).
    Nakatani T; Marui T; Yamamoto T; Hitora T; Akisue T; Kawamoto T; Nagira K; Fujita I; Matsumoto K; Yoshiya S; Kurosaka M
    Anticancer Res; 2003; 23(3B):2329-33. PubMed ID: 12894511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KIT activation in uterine cervix adenosquamous carcinomas by KIT/SCF autocrine/paracrine stimulation loops.
    Martinho O; Gonçalves A; Moreira MA; Ribeiro LF; Queiroz GS; Schmitt FC; Reis RM; Longatto-Filho A
    Gynecol Oncol; 2008 Nov; 111(2):350-5. PubMed ID: 18708242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The stem cell factor/c-kit receptor pathway enhances proliferation and invasion of pancreatic cancer cells.
    Yasuda A; Sawai H; Takahashi H; Ochi N; Matsuo Y; Funahashi H; Sato M; Okada Y; Takeyama H; Manabe T
    Mol Cancer; 2006 Oct; 5():46. PubMed ID: 17044945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coexpression of the c-kit receptor and the stem cell factor in gynecological tumors.
    Inoue M; Kyo S; Fujita M; Enomoto T; Kondoh G
    Cancer Res; 1994 Jun; 54(11):3049-53. PubMed ID: 7514496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-KIT and c-KIT ligand (SCF) in synovial sarcoma (SS): an mRNA expression analysis in 23 cases.
    Tamborini E; Papini D; Mezzelani A; Riva C; Azzarelli A; Sozzi G; Pierotti MA; Pilotti S
    Br J Cancer; 2001 Aug; 85(3):405-11. PubMed ID: 11487273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of stem cell factor (SCF) and SCF receptor (c-kit) in synovial membrane in arthritis: correlation with synovial mast cell hyperplasia and inflammation.
    Ceponis A; Konttinen YT; Takagi M; Xu JW; Sorsa T; Matucci-Cerinic M; Santavirta S; Bankl HC; Valent P
    J Rheumatol; 1998 Dec; 25(12):2304-14. PubMed ID: 9858422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem cell factor is not essential for cell survival and proliferation of soft tissue sarcoma of neuroectodermal origin.
    Ricotti E; Bertorello N; Vai S; Pagani A; Cordero Di Montezemolo L; Madon E; Basso G
    Haematologica; 1999 Oct; 84(10):879-86. PubMed ID: 10509034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem cell factor-KIT signalling plays a pivotal role in regulating pigmentation in mammalian hair.
    Hachiya A; Sriwiriyanont P; Kobayashi T; Nagasawa A; Yoshida H; Ohuchi A; Kitahara T; Visscher MO; Takema Y; Tsuboi R; Boissy RE
    J Pathol; 2009 May; 218(1):30-9. PubMed ID: 19214986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of stem cell factor and c-kit signaling in regulation of fetal intestinal epithelial cell adhesion to fibronectin.
    Shimizu M; Minakuchi K; Tsuda A; Hiroi T; Tanaka N; Koga J; Kiyono H
    Exp Cell Res; 2001 Jun; 266(2):311-22. PubMed ID: 11399059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-kit receptor expression in Ewing's sarcoma: lack of prognostic value but therapeutic targeting opportunities in appropriate conditions.
    Scotlandi K; Manara MC; Strammiello R; Landuzzi L; Benini S; Perdichizzi S; Serra M; Astolfi A; Nicoletti G; Lollini PL; Bertoni F; Nanni P; Picci P
    J Clin Oncol; 2003 May; 21(10):1952-60. PubMed ID: 12743148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of stem cell factor (SCF), a KIT ligand, in gastrointestinal stromal tumors (GISTs): a potential marker for tumor proliferation.
    Hirano K; Shishido-Hara Y; Kitazawa A; Kojima K; Sumiishi A; Umino M; Kikuchi F; Sakamoto A; Fujioka Y; Kamma H
    Pathol Res Pract; 2008; 204(11):799-807. PubMed ID: 18602222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
    Engelhardt M; Drullinsky P; Guillem J; Moore MA
    Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.